RG14620 100 mg | 99.56%
TargetMol
RG14620
Search Results
SHP099 hydrochloride 5 mg | 99.62%
TargetMol
SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.
More Information Supplier PageSHP099 hydrochloride
SHP099 hydrochloride 50 mg | 99.62%
TargetMol
SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.
More Information Supplier PageSHP099 hydrochloride
SHP099 hydrochloride 1 mg | 99.62%
TargetMol
SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.
More Information Supplier PageSHP099 hydrochloride
SHP099 hydrochloride 10 mg | 99.62%
TargetMol
SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.
More Information Supplier PageSHP099 hydrochloride
Benurestat 2 mg | 99.95%
TargetMol
Benurestat
Benurestat 10 mg | 99.95%
TargetMol
Benurestat
AM-2394 5 mg | 99.58%
TargetMol
AM-2394 is an effective and specific Glucokinase agonist (GKA, EC50: 60 nM), which catalyzes the phosphorylation of glucose to glucose-6-phosphate. AM-2394(AM2394) increases the affinity of GK for glucose by approximately 10-fold, exhibits moderate clearance and good oral bioavailability in multiple animal models, and lowers glucose excursion following an oral glucose tolerance test in an ob/ob […]
More Information Supplier PageAM-2394
AM-2394 50 mg | 99.58%
TargetMol
AM-2394 is an effective and specific Glucokinase agonist (GKA, EC50: 60 nM), which catalyzes the phosphorylation of glucose to glucose-6-phosphate. AM-2394(AM2394) increases the affinity of GK for glucose by approximately 10-fold, exhibits moderate clearance and good oral bioavailability in multiple animal models, and lowers glucose excursion following an oral glucose tolerance test in an ob/ob […]
More Information Supplier PageAM-2394
AM-2394 10 mg | 99.58%
TargetMol
AM-2394 is an effective and specific Glucokinase agonist (GKA, EC50: 60 nM), which catalyzes the phosphorylation of glucose to glucose-6-phosphate. AM-2394(AM2394) increases the affinity of GK for glucose by approximately 10-fold, exhibits moderate clearance and good oral bioavailability in multiple animal models, and lowers glucose excursion following an oral glucose tolerance test in an ob/ob […]
More Information Supplier PageAM-2394